HAUS OF LABS

TIRZEPATIDE 30mg

Dual GIP & GLP-1 Receptor Agonist

Tirzepatide is a long-acting synthetic peptide that targets both GIP and GLP-1 receptors, two important pathways involved in appetite, glucose regulation and metabolic signalling.

How It Works:

By activating both GIP and GLP-1 receptors, tirzepatide influences several physiological processes associated with metabolic regulation. These include reduced calorie intake, appetite signalling, glucose-dependent insulin secretion and suppression of glucagon secretion.

Tirzepatide also contains a lipid side chain that increases albumin binding and extends its duration of activity, allowing it to act as a long-acting peptide.

Research Areas:

• Dual GIP/GLP-1 receptor activation
• Appetite and caloric-intake regulation
• Glucose metabolism
• Insulin and glucagon signalling
• Body-weight regulation
• Metabolic pathway research

Product: Tirzepatide
Strength: 30mg
Format: Vial

Research use only. Not for human consumption.